Login
Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin

News

14 March 2014

The new wave of medtech

In a new report, Silicon Valley Comes to the UK and Nesta present a snapshot of the early breakers in medtech.

Nesta Medtech ReportHealthcare technology often brings to mind images of hard to reach technologies that require highly skilled technicians and years of training to use. But there is another group of accessible, portable and easy to use medical technologies arriving on the scene - a new wave of medtech.

A new wave of medical technologies offers novel business opportunities. In a new report, Silicon Valley Comes to the UK and Nesta present a snapshot of the early breakers, including, Cambridge Cognition.

In a new report, Silicon Valley Comes to the UK and Nesta present a snapshot of the early breakers in medtech.

Nesta is the UK’s innovation foundation, an independent charity, helping people and organisations bring ideas to life. In this report, Silicon Valley Comes to the UK (SVC2UK) and Nesta present an overview of innovative companies and how they will play into changes in the broader healthcare sector.

Connectivity has enabled real–time data streaming and visualisation allowing technology like Cantab Mobile to check patient responses against expectations, measure, monitor and recommended procedural modifications (e.g. to accelerate patient enrolment) for research and clinical institutions even as the trial is progressing – reducing costs and improving data quality. Cambridge Cognition’s research team use this type of information to test the underlying software, providing phased updates of reference standards for assessing patients. 

Andy Blackwell, Chief Scientific Officer, comments: “The report brings together all the relevant issues facing provision of healthcare in the UK and the inclusion of Cambridge Cognition is a testament to the quality of our products and the years of research that has lead us to be recognised in this prestigious report for our ability to identify and therefore treat cognitive disease earlier.”